Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Likai Mao

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Development, Growth & Differentiation|December 21, 2004
Sustained MAPK activation is dependent on continual NGF receptor regenerationDongru Qiu, Likai Mao, Shinichi Kikuchi, et al.
Oncology Letters|December 7, 2020
Antitumour activity of TH1579, a novel MTH1 inhibitor, against castration-resistant prostate cancerMingqiu Hu, Jing Ning, Likai Mao, et al.
Discover Oncology|October 24, 2025
RAD51-AS1 inhibits the migration and invasion of prostate cancer cells by up-regulating RARA to activate ZYX transcriptionZhijun Chen, Xinwei Wang, Likai Mao, et al.
Cancer Management and Research|January 7, 2021
Identification of Core Genes Involved in the Metastasis of Clear Cell Renal Cell CarcinomaRui Peng, Yahui Wang, Likai Mao, et al.
Carcinogenesis|March 4, 2025
LncRNA MEG3 suppresses prostate cancer progression by mediating macrophage polarization via the miR-148a-3p/ARRDC3 signaling axisJinguang Luo, Huaixiang Tao, Long Chen, et al.
Experimental Cell Research|April 22, 2020
Injured tubular epithelial cells activate fibroblasts to promote kidney fibrosis through miR-150-containing exosomesHan Guan, Rui Peng, Likai Mao, et al.
Frontiers in Immunology|June 16, 2025
Investigation of GPR137C as a promising novel marker for the progression of prostate cancer through G4 screen and bioinformatics analysesYue Hou, Haowen Lu, Saisai Chen, et al.
The ISME Journal|October 7, 2018
Antiepileptic drug carbamazepine promotes horizontal transfer of plasmid-borne multi-antibiotic resistance genes within and across bacterial generaYue Wang, Ji Lu, Likai Mao, et al.
Cancer Medicine|February 21, 2019
MicroRNA-200a suppresses prostate cancer progression through BRD4/AR signaling pathwayHan Guan, Zonghao You, Can Wang, et al.
Medicine|December 19, 2018
The impact of pre-existing cancer on survival of prostate cancer patients: A population-based studyYuan Zhou, Han Guan, Yong Fu, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Development, Growth & Differentiation|December 21, 2004
Sustained MAPK activation is dependent on continual NGF receptor regenerationDongru Qiu, Likai Mao, Shinichi Kikuchi, et al.
Oncology Letters|December 7, 2020
Antitumour activity of TH1579, a novel MTH1 inhibitor, against castration-resistant prostate cancerMingqiu Hu, Jing Ning, Likai Mao, et al.
Discover Oncology|October 24, 2025
RAD51-AS1 inhibits the migration and invasion of prostate cancer cells by up-regulating RARA to activate ZYX transcriptionZhijun Chen, Xinwei Wang, Likai Mao, et al.
Cancer Management and Research|January 7, 2021
Identification of Core Genes Involved in the Metastasis of Clear Cell Renal Cell CarcinomaRui Peng, Yahui Wang, Likai Mao, et al.
Carcinogenesis|March 4, 2025
LncRNA MEG3 suppresses prostate cancer progression by mediating macrophage polarization via the miR-148a-3p/ARRDC3 signaling axisJinguang Luo, Huaixiang Tao, Long Chen, et al.
Experimental Cell Research|April 22, 2020
Injured tubular epithelial cells activate fibroblasts to promote kidney fibrosis through miR-150-containing exosomesHan Guan, Rui Peng, Likai Mao, et al.
Frontiers in Immunology|June 16, 2025
Investigation of GPR137C as a promising novel marker for the progression of prostate cancer through G4 screen and bioinformatics analysesYue Hou, Haowen Lu, Saisai Chen, et al.
The ISME Journal|October 7, 2018
Antiepileptic drug carbamazepine promotes horizontal transfer of plasmid-borne multi-antibiotic resistance genes within and across bacterial generaYue Wang, Ji Lu, Likai Mao, et al.
Cancer Medicine|February 21, 2019
MicroRNA-200a suppresses prostate cancer progression through BRD4/AR signaling pathwayHan Guan, Zonghao You, Can Wang, et al.
Medicine|December 19, 2018
The impact of pre-existing cancer on survival of prostate cancer patients: A population-based studyYuan Zhou, Han Guan, Yong Fu, et al.
Pageof 5